Search results
After a year of 4.1% returns, Arrowhead Pharmaceuticals, Inc.'s (NASDAQ:ARWR) share price drop last...
Simply Wall St. via Yahoo Finance· 11 months agoKey Insights Significantly high institutional ownership implies Arrowhead Pharmaceuticals' stock...
Is Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Expensive For A Reason? A Look At Its Intrinsic...
Simply Wall St. via Yahoo Finance· 2 months agoKey Insights Using the 2 Stage Free Cash Flow to Equity, Arrowhead Pharmaceuticals fair value...
Arrowhead Pharmaceuticals, Inc.'s (NASDAQ:ARWR) Shares Climb 25% But Its Business Is Yet to Catch Up
Simply Wall St. via Yahoo Finance· 1 year agoThose holding Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) shares would be relieved that the share...
Investing in Arrowhead Pharmaceuticals (NASDAQ:ARWR) five years ago would have delivered you a 982%...
Simply Wall St. via Yahoo Finance· 2 years agoArrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) shareholders have seen the share price descend 19%...
Institutional investors may adopt severe steps after Arrowhead Pharmaceuticals, Inc.'s (NASDAQ:ARWR)...
Simply Wall St. via Yahoo Finance· 2 weeks agoKey Insights Significantly high institutional ownership implies Arrowhead Pharmaceuticals' stock...
Great week for Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) institutional investors after losing...
Simply Wall St. via Yahoo Finance· 6 months agoKey Insights Institutions' substantial holdings in Arrowhead Pharmaceuticals implies that they have...
Is Arrowhead Pharmaceuticals (ARWR) Too Good to Be True? A Comprehensive Analysis of a ...
GuruFocus.com via Yahoo Finance· 8 months agoFor value-focused investors, the quest for stocks trading below their intrinsic value is relentless....
Swelling losses haven't held back gains for Arrowhead Pharmaceuticals (NASDAQ:ARWR) shareholders...
Simply Wall St. via Yahoo Finance· 9 months agoIt hasn't been the best quarter for Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) shareholders,...
Insider Sell Alert: Chief Medical Officer Martin San Sells 19,700 Shares of Arrowhead ...
GuruFocus.com via Yahoo Finance· 5 months agoArrowhead Pharmaceuticals Inc (NASDAQ:ARWR) has recently witnessed a significant insider sell by its...
Arrowhead Pharmaceuticals Surges After Hinting At A Midstage Win In Liver Disease
Investor's Business Daily· 1 year agoArrowhead Pharmaceuticals has provided a bullish update for its midstage liver disease treatment,...